SURPRISE OF THE YEAR Why General Motors is Yahoo Finance's 2024 winner HKSE - Delayed Quote • HKD Li Auto Inc. (2015.HK) Follow Compare 85.250 -0.200 (-0.23%) At close: 4:08:10 PM GMT+8 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Are Investors Undervaluing Li Auto Inc. (NASDAQ:LI) By 27%? Key Insights The projected fair value for Li Auto is US$30.35 based on 2 Stage Free Cash Flow to Equity Li Auto is... Is It Worth Investing in Li Auto (LI) Based on Wall Street's Bullish Views? The average brokerage recommendation (ABR) for Li Auto (LI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? Li Auto Sees Surge in Deliveries and Market Dominance Li Auto (LI) has released an update. Li Auto has reported impressive growth with 48,740 vehicles delivered in November 2024, marking an 18.8% increase compared to the previous year. The company continues to dominate the Chinese new energy vehicle market, particularly in the premium segment, with significant demand for its autonomous driving technologies. Li Auto’s strategic expansion of retail, service, and charging infrastructure positions it for sustained success. For further insights into LI NIO, XPeng & Li Auto Provide Delivery Results for November NIO, XPEV and LI report a year-over-year rise in November deliveries. XPeng Stock Jumps On Record Deliveries. Why December Should Be Even Better. The midpoint of its fourth-quarter guidance, given on its third-quarter earnings report, was 89,000 cars, implying December deliveries of about 34,000 units. Citi analyst Jeff Chung recently wrote that the Chinese car market is still concerned about a “potential price war in 2025.” BYD Smashes Records as Tesla Rivals Shake Up China's EV Market in November XPeng, Zeekr Surge While Nio, Li Auto Struggle in China's EV Sales Battle Tesla, BYD Ramp Up China Incentives in End-of-Year Sales Push (Bloomberg) -- Electric car makers including Tesla Inc. and BYD Co. have unleashed further discounts and incentives in China in a final push to meet annual sales targets.Most Read from BloombergAs Wars Rage, Cities Face a Dark New Era of Urban DestructionRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsTesla is offering five-year 0% loans and a 10,000 yuan ($1,380) discount on its Model Y sport utility vehicle until the end of December, according to a post on the company’s Weibo ac Li Auto Inc. November 2024 Delivery Update BEIJING, China, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 48,740 vehicles in November 2024, up 18.8% year over year. As of November 30, 2024, Li Auto had delivered a total of 441,995 vehicles in 2024, with cumulative deliveries reaching 1,075,359. Li Auto maintained its best-selling position among Chinese automotive brands in the RMB200,000 and above passen Hong Kong Shares End Higher; Auto, Entertainment Stocks Lead Gains The Hang Seng closed slightly higher supported by auto and entertainment stocks, with investors closely watching for announcements related to the upcoming central government work conference, which could be the next platform for stimulus. Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced successful completion of an $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Emer Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D E Growth Companies With High Insider Ownership On US Exchanges November 2024 As the U.S. stock market experiences a pause in its recent rally, with technology shares leading the decline, investors are closely monitoring economic indicators and Federal Reserve decisions that could influence future interest rates. In this environment of fluctuating indices, companies with strong growth potential and significant insider ownership can offer a unique appeal, suggesting confidence from those who know the business best. Remy Cointreau’s Long-Term Story Remains Attractive Remy Cointreau shares gained sharply despite it warning of a weaker outlook in 2025, with Jefferies saying the drinks group’s long-term business remained compelling. Exclusive-China's Hesai to halve lidar prices next year, sees wide adoption in electric cars China's Hesai Group, the world's largest maker of lidar sensors for autonomous driving, said it plans to slash the price of its key product by half next year which should lead to far wider adoption of the technology in electric cars. "We are moving to a stage where millions of cars sold annually are equipped with lidar," Chief Executive David Li told Reuters in an interview. For electric cars priced above that, the adoption rate for lidar technology would likely jump to 40%, Li also said. US Exchange Stocks Estimated Up To 29.8% Below Intrinsic Value As the U.S. stock market experiences a period of mixed futures and weekly gains, investors are closely watching major indices like the Dow Jones Industrial Average and S&P 500 for signs of sustained recovery following recent fluctuations. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors seeking to capitalize on market inefficiencies. NIO Q3 Loss Wider Than Expected, Revenues Miss, Q4 View Solid For fourth-quarter 2024, NIO projects deliveries in the range of 72,000-75,000 vehicles, implying a rise of 43.9-49.9% year over year. Is Li Auto (LI) a Buy as Wall Street Analysts Look Optimistic? The average brokerage recommendation (ABR) for Li Auto (LI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? Li Auto Inc. (NASDAQ:LI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? It is hard to get excited after looking at Li Auto's (NASDAQ:LI) recent performance, when its stock has declined 10... 3 Top EV Stocks to Buy in November The soft Chinese economy and an EV pricing war exacerbated that pressure. Let's examine three of those stocks -- Nio (NYSE: NIO), Li Auto (NASDAQ: LI), and Joby Aviation (NYSE: JOBY) -- and see why they're worth nibbling on in November. Nio is a Chinese EV maker that produces electric sedans and SUVs. Is Li Auto Stock’s (LI) Selloff Justified as Trump Vows to Raise Tariffs? Li Auto (LI) stock is down more than 7% in Friday’s trading session. The selloff appeared to be a direct reaction to the U.S. election result, with president-elect Donald Trump vowing to raise tariffs on Chinese imports. However, Li Auto doesn’t export to the U.S. and doesn’t have plans to. As such, I think the selloff is unwarranted. More broadly, I think the stock is oversold and undervalued based on projected earnings growth. That’s why I’m bullish. Trump’s Tariffs Donald Trump is the preside Performance Overview Trailing total returns as of 12/17/2024, which may include dividends or other distributions. Benchmark is HANG SENG INDEX Return 2015.HK HANG SENG INDEX YTD -42.05% +15.56% 1-Year -38.93% +17.32% 3-Year -29.43% -16.08%